CAS 209219-38-5

Z-360

Description:

Z-360, with the CAS number 209219-38-5, is a chemical compound that has garnered attention in various fields, particularly in research and development. While specific characteristics can vary based on its formulation and application, Z-360 is generally recognized for its role as a selective inhibitor in biochemical pathways. It is often studied for its potential therapeutic applications, particularly in the context of cancer research and other diseases where modulation of specific cellular processes is beneficial. The compound may exhibit properties such as solubility in organic solvents, stability under certain conditions, and the ability to interact with specific biological targets. Safety data sheets and material safety data sheets (MSDS) should be consulted for detailed information regarding handling, toxicity, and environmental impact. As with any chemical substance, proper laboratory practices and safety protocols should be followed when working with Z-360 to ensure safe usage and minimize risks.

Nastorazepide

CAS: 209219-38-5

Nastorazepide

Purity: ≥98%

Molecular weight: 520.62g/mol

Ref: 54-BUP09070

Nastorazepide

CAS: 209219-38-5

Nastorazepide is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.

Formula: C₂₉H₃₆N₄O₅

Purity: 99.83%

Color and Shape: Solid

Molecular weight: 520.62

Ref: TM-TQ0062

Nastorazepide

Controlled Product

CAS: 209219-38-5

Nastorazepide is a pyrimidine compound that inhibits the production of chemokines and growth factors, which are important in the development of inflammatory bowel disease. Nastorazepide also has diagnostic properties, as its anti-inflammatory effects can be used to differentiate between Crohn's disease and ulcerative colitis. This agent also inhibits tumor angiogenesis, leading to decreased metastatic pancreatic cancer.

Formula: C₂₉H₃₆N₄O₅

Purity: Min. 95%

Molecular weight: 520.62 g/mol

Ref: 3D-JIA21938